Co-Codamol 30/500mg Effervescent Tablets
PATIENT INFORMATION LEAFLET CO-CODAMOL 30/500 mg EFFERVESCENT TABLETS
The name of this medicine is Co-codamol 30/500 mg Effervescent Tablets, which will be referred to as Co-codamol 30/500 throughout this leaflet.
Read all of this leaflet carefully before you start taking this medicine.
• Keep this leaflet. You may need to read it again.
• If you have further questions, please ask your doctor or your pharmacist.
• This medicine has been prescribed for you. Do not pass it on to others; it may harm them, even if their symptoms are the same as yours.
• If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
In this leaflet:
1. What Co-codamol 30/500 are and what they are used for
2. Before you take Co-codamol 30/500
3. How to take Co-codamol 30/500
4. Possible side effects
5. How to store Co-codamol 30/500
6. Further information
1. WHAT CO-CODAMOL 30/500 ARE AND WHAT THEY ARE USED FOR
The active ingredients in Co-codamol 30/500 are paracetamol and codeine phosphate hemihydrate.
This product contains codeine. Codeine belongs to a group of medicines called opioid analgesics which act to relieve pain. It can be used on its own or in combination with other pain killers. Codeine can be used in children over 12 years of age for short-term relief of moderate pain that is not relieved by other painkillers such as paracetamol or ibuprofen alone.
2. BEFORE YOU TAKE CO-CODAMOL 30/500
Do not take Co-codamol 30/500 if you:
• know that you metabolise very rapidly codeine into morphine
• are breast feeding
• are a child or adolescents for pain relief (0-18 years of age) after removal of your tonsils or adenoids due to obstructive sleep apnoea syndrome
• are a child under 12 years old
• are allergic (hypersensitive) to paracetamol, codeine or any of the other ingredients in the tablets (these are listed in Section 6, Further Information)
• are already taking other medicines containing paracetamol
• have a dependency to alcohol
• suffer from acute asthma
• have liver or kidney problems
• are on a low sodium diet
• have bowel or prostate problems
• are receiving monoamine oxidase inhibitor (MAOI) therapy. Co-codamol 30/500 should not be taken concurrently or within 14 days of MAOI's
Take special care with Co-codamol 30/500:
• If you have an under-active thyroid gland
• If you have a disease of the Adrenal gland called Addison's disease
• If you have a condition which weakens the muscles called myasthenia gravis
Page 1
• If you are elderly
• If you feel weak
• If you are debilitated
• Do not take for longer than directed by your doctor or pharmacist.
• Taking codeine regularly for a long period of time can lead to addiction, which might cause you to feel restless and irritable when you stop taking the tablets.
• T aking a painkiller for headaches too often or for too long can make them worse. Warnings and Precautions
Codeine is transformed to morphine in the liver by an enzyme. Morphine is the substance that produces pain relief. Some people have a variation of this enzyme and this can affect people in different ways. In some people, morphine is not produced or produced in very small quantities, and it will not provide enough pain relief. Other people are more likely to get serious side effects because a very high amount of morphine is produced. If you notice any of the following side effects, you must stop taking this medicine and seek immediate medical advice: slow or shallow breathing, confusion, sleepiness, small pupils, feeling or being sick, constipation, lack of appetite.
Children and adolescents
Use in children and adolescents after surgery: Codeine should not be used for pain relief in children and adolescents after removal of their tonsils or adenoids due to Obstructive Sleep Apnoea Syndrome.
Use in children with breathing problems: Codeine is not recommended in children with breathing problems, since the symptoms of morphine toxicity may be worse in these children.
Taking other medicines
Do not take these tablets if you are already taking other medicines containing paracetamol.
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription, as they may decrease or increase the effect of Co-codamol 30/500:
• metoclopramide or domperidone (often taken for sickness or stomach problems)
• colestyramine (for high blood lipid levels)
• anticoagulants to reduce blood clotting (e.g. warfarin)
• MAOI's and CNS depressants such as sleeping tablets, sedatives and some antihistamines
It may still be all right for you to take Co-codamol 30/500 and your doctor will be able to decide what is suitable for you.
Taking your medicine with food and drink
Co-codamol 30/500 should be dissolved in at least half a glass of water and can be taken with or without a meal.
Pregnancy, breast-feeding and fertility
Although there is no evidence that these tablets cause any ill effects during pregnancy, your doctor should advise you about taking them if you are pregnant.
Do not take codeine while you are breast feeding. Codeine and morphine passes into breast milk.
Ask your doctor or pharmacist for advice before taking any medicines.
Driving and using machinery
These tablets may make you feel dizzy or drowsy. If this happens do not drive or operate machinery.
Important information about some of the ingredients of Co-codamol 30/500
Each of these tablets contains about 438 mg of sodium and may interfere if you are on a low sodium diet.
X
This product also contains aspartame (a source of phenylalanine), which should not be given to anyone with phenylketonuria.
AXP025FUD
Page 2
CO-CODAMOL 30/500 mg EFFERVESCENT TABLETS
PHARMACODE
XXXXX
xxxxx
V3tdV
3aoovi/\mvHd
S1319V1
lN3DS3A!d3dd3 Bui 00S/0S
loiAivaoc-oc
3. HOW TO TAKE CO-CODAMOL 30/500
4. POSSIBLE SIDE EFFECTS
6. FURTHER INFORMATION
Cipla Inventory Code
Do not exceed the recommended doses. If painful symptoms are not relieved in a few days, consult your doctor.
Dosage
The usual doses for Co-codamol 30/500 are as follows:
Adults:
Should take 1 or 2 tablets dissolved in water every 4-6 hours, as needed. Do not take more than 8 tablets in 24 hours.
Children over 12 years:
Children aged 12 years and above should take 1 or 2 tablets dissolved in water every 6 hours, as needed. Do not take more than 8 tablets in 24 hours.
This medicine should not be taken for more than 3 days. If the pain does not improve after 3 days, talk to your doctor for advice.
Co-codamol 30/500 should not be taken by children below the age of 12 years, due to the risk of severe breathing problems.
Method of Administration
For oral administration only. These tablets should be dissolved in at least half a glass of water before taking them. The solution should be drunk immediately after preparation. These tablets are meant to be dissolved first so don't try to swallow them whole.
If you take more Co-codamol 30/500 than you should
Talk to your doctor at once if you take too much of this medicine even if you feel well. This is because too much paracetamol can cause delayed serious liver damage. Remember to take the pack and any remaining tablets with you.
If you forget to take Co-codamol 30/500
If you forget to take one or more doses, take your next dose when you remember and then go on as prescribed. Do not take a double dose to make up for a forgotten dose.
If you have any further questions about this product ask your doctor or pharmacist.
Like all medicines, Co-codamol 30/500 can cause side effects although not everybody gets them. If you get any of the following symptoms after taking these tablets, you should contact your doctor immediately:
• Any sudden wheeziness, difficulty in breathing or dizziness, swelling of the eyelids, face, lips or throat.
• An acute allergic reaction (anaphylaxis) or swelling of the skin.
The following effects have been reported:
• Mood changes
• Stomach pains
• Deafness
• Skin rashes
• Constipation
• Nausea, vomiting
• Light-headedness, dizziness,
• Confusion
• Drowsiness
• Urinary retention
• Rarely pancreatitis (inflammation of the pancreas which may cause severe abdominal pain that can spread through to your back)
There have been very rare reports of blood problems, so if you notice unusual bleeding or you bruise easily, tell your doctor as soon as possible.
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard. By reporting side effects, you can help provide more information on the safety of this medicine.
5. HOW TO STORE CO-CODAMOL 30/500
Do not store your tablets above 25°C. Store in a dry place and protect from light.
Do not take this medicine after the expiry date stated on the carton. The expiry date refers to the last day of that month.
Keep all medicines out of the sight and reach of children.
Medicines should not be disposed of via wastewater or household waste.
Ask your pharmacist how to dispose of medicines no longer required.
These measures will help to protect the environment.
What Co-codamol 30/500 mg Effervescent Tablets contain:
The active ingredients are paracetamol and codeine phosphate hemihydrate. Each tablet contains 500mg paracetamol and 30mg codeine phosphate hemihydrate.
The other ingredients are sodium hydrogen carbonate, citric acid anhydrous, sodium carbonate, povidone, simeticone, sodium saccharin, aspartame (E951) and polysorbate 80.
What Co-codamol 30/500 look like and the contents of the pack:
Co-codamol 30/500 mg Effervescent Tablets are white, circular, with a flat bevelled edge and plain on both sides.
Your medicine is available in blister packs of 30, 32, 56, 60, 84, 90 and 100 tablets (not all pack sizes may be marketed).
Marketing Authorisation Holder:
Fannin (UK) Limited, 42-46 Booth Drive, Park Farm South, Wellingborough, Northamptonshire, NN8 6GT, UK.
Manufacturer responsible for batch release:
Kent Pharmaceuticals Limited, Crowbridge Road, Ashford, Kent, TN24 0GR,
Kent Pharmaceuticals Limited, Repton Road, Measham, DE12 7DT, U.K.
This leaflet was last approved in June 2015.
AXP025FUD
Product Name : Co-codamol 30-500mg (PIL)
Coordinator : K
Fonts : Convert to curve
Colours :
BLUE WOOL TEST VALUE 5-8 (LIGHT FASTENING DATA)
Item Code : XXXXX Item : PIL | Date : 21-06-13 (16-10-13)
Artist : A
Pantone Black C
Spectro-Densitometer Delta-E reading (A E) for colour: NOT MORE THAN dE2.5
Supersedes / Reference :
Screen : # 150
Software : Illustrator CS5
Glossmeter reading
(for white surface): NOT LESS THAN 80 %
Unwinding Direction :
Tuck flap:
Side / Collar flap overlap:
Caliper (Thickness) for Board:
Links :
Pharmacode :
Design : Folded
Material : 42 GSM ITC Printing Paper.
Varnish :
Actual Size : 335 x 250mm
Size after Folding : 37 x 31mm
Print repeat length :
Grain Direction : Perpendicular to Crease / Perpendicular to Pasting Flap / Parallel to length
Reference / Instructions / Remark / Braille Text Embossing:
Artwork Print Size: | | actual | | scaled
Path : F:a/P/Fannin/Co-codamol Effer. Tab.Fanni/Co-codamol 30-500 Effer (Add change) Fannin COA. Tab.ai
|
Checked by |
Artist |
Cordinator |
Section Head |
File Copied by: |
file loaded in BCT HO |
|
Pharma Code |
□ |
□ | |||
|
2D Code |
□ |
□ | |||
|
Barcode Code |
□ |
□ | |||
|
Artwork |
□ |
□ | |||
|
Spell check |
□ |
□ |
Date: |
NOTE TO THE PRINTER :
• Return approved artwork alongwith the proof.
• The proof must be verified against the approved hardcopy, should be certified and signed by an authorised QA person. The unsigned proof will not be accepted.
• Colour scheme must be as approved by packaging development co-ordinator.
• Any deviation must be brought to the notice of packaging development co-ordinator immediately.
• For any clarification, please contact packaging development co-ordinator immediately.